1. Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Non compete

Discussion in 'NuVasive' started by Anonymous, Jun 23, 2013 at 7:11 PM.

  1. Anonymous

    Anonymous Guest

    Just curious, how are so many ex-MDT people able to just go to NuVasive without any non-compete issues?
     
  2. Anonymous

    Anonymous Guest

    NUVA technically and financially died awhile back. The same guy Obama got to do the financial trickery to bail out GM, also dumped money into NUVA to keep it going.

    The money schemers won't let NUVA die, they'll shuffle people in they want having jobs right now.....and now look....they've expanded the dead horse to Australia, South America, Japan, Europe.

    NOBODY is going to quit their jobs in other spine companies to jump on NUVA's ship. The people you're referring to.....we're likely released from employment from the other company.......poor performers.....personal issues.

    Good enough to ride a dead horse tho.


    YOU DO NOT want to be in one of those foreign jobbers. Suicide mission.

    Imagine what repercussions they'll face when patients are dropping dead and they find out the NUVA surgical tools couldn't be dissassembled to sterilize, COROENT XL now requires new FDA label on the box saying it can't bear loads, all the post surgical infections that've killed off patients...failed fusions because they didn't use fixation....majic pixie dust put inside the plastic disc spacers didn't pan out like they advertised....some was made from cadavers they later found has baaaaad diseases. And got recalled too late. Already was out in the market.

    You'd need some disposable people to work those overseas ops pushing the product.